Virtual Roundtable Series; Does Physiological Complexity Kill Scalability?
New Frontiers in 3D Digital event - Virtual Roundtable Series: Does Physiological Complexity Kill Scalability?
Join for a virtual fireside chat about industrial applications for complex, yet scalable in vitro models for drug discovery. In this live, interactive roundtable, the panelists will discuss the importance of balancing experimental complexity and scalability, and how thoughtful engineering can ensure successful translation from academia to industry. They will explore key topics, such as:
- Why are biological complexity and experimental scalability both essential for producing meaningful and robust datasets?
- What are the trade-offs between complexity and scalability?
- In which stages of research and development is scalability most critical?
- How does scalability of complex systems influence drug development?
- What are the next steps to ensure translatability of complex model systems
hDMT member Prof Jaap den Toonder (TU Eindhoven) will take place in the panel.
Prof. Jaap den Toonder, Professor and Chair of the Microsystems section, Eindhoven University of Technology
Prof. Peter Loskill, Assistant Professor, Research Institute for Women's Health, Eberhard Karls University Tübingen
Dr. Florian Fuchs, Senior Principle Scientist, Nuvisan Innovation Campus Berlin
Dr. Olivier Frey, Head of Platforms and Technologies, InSphero AG
Registration is open.